These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15469196)

  • 41. Neurobiological background of negative symptoms.
    Galderisi S; Merlotti E; Mucci A
    Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):543-58. PubMed ID: 25797499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated striatal dopamine attenuates nigrothalamic inputs and impairs transthalamic cortico-cortical communication in schizophrenia: a hypothesis.
    Vukadinovic Z
    Med Hypotheses; 2015 Jan; 84(1):47-52. PubMed ID: 25433955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormalities of thalamic activation and cognition in schizophrenia.
    Andrews J; Wang L; Csernansky JG; Gado MH; Barch DM
    Am J Psychiatry; 2006 Mar; 163(3):463-9. PubMed ID: 16513868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?
    Andreasen NC; Paradiso S; O'Leary DS
    Schizophr Bull; 1998; 24(2):203-18. PubMed ID: 9613621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia.
    Lewis DA; Pierri JN; Volk DW; Melchitzky DS; Woo TU
    Biol Psychiatry; 1999 Sep; 46(5):616-26. PubMed ID: 10472415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia.
    Meador-Woodruff JH; Clinton SM; Beneyto M; McCullumsmith RE
    Ann N Y Acad Sci; 2003 Nov; 1003():75-93. PubMed ID: 14684436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dysregulation of thalamic sensory "transmission" in schizophrenia: neurochemical vulnerability to hallucinations.
    Behrendt RP
    J Psychopharmacol; 2006 May; 20(3):356-72. PubMed ID: 16174672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Glutamatergic neurotransmission in schizophrenics].
    Bleich S; Bleich K; Wiltfang J; Maler JM; Kornhuber J
    Fortschr Neurol Psychiatr; 2001 Sep; 69 Suppl 2():S56-61. PubMed ID: 11533851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurobiology of schizophrenia.
    Egan MF; Weinberger DR
    Curr Opin Neurobiol; 1997 Oct; 7(5):701-7. PubMed ID: 9384552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging.
    Portas CM; Goldstein JM; Shenton ME; Hokama HH; Wible CG; Fischer I; Kikinis R; Donnino R; Jolesz FA; McCarley RW
    Biol Psychiatry; 1998 May; 43(9):649-59. PubMed ID: 9582998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cortical brain dysfunction in early schizophrenia: secondary pathogenetic hierarchy of neuroplasticity, psychopathology and social impairment.
    Hemmingsen R; Madsen A; Glenthøj B; Rubin P
    Acta Psychiatr Scand Suppl; 1999; 395():80-8. PubMed ID: 10225336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thalamo-cortical communication, glutamatergic neurotransmission and neural oscillations: A unique window into the origins of ScZ?
    Pratt J; Dawson N; Morris BJ; Grent-'t-Jong T; Roux F; Uhlhaas PJ
    Schizophr Res; 2017 Feb; 180():4-12. PubMed ID: 27317361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia.
    Ibrahim HM; Hogg AJ; Healy DJ; Haroutunian V; Davis KL; Meador-Woodruff JH
    Am J Psychiatry; 2000 Nov; 157(11):1811-23. PubMed ID: 11058479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural and functional dysconnectivity of the fronto-thalamic system in schizophrenia: a DCM-DTI study.
    Wagner G; De la Cruz F; Schachtzabel C; Güllmar D; Schultz CC; Schlösser RG; Bär KJ; Koch K
    Cortex; 2015 May; 66():35-45. PubMed ID: 25797657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurochemical substrates and neuroanatomical generators of the event-related P300.
    Frodl-Bauch T; Bottlender R; Hegerl U
    Neuropsychobiology; 1999; 40(2):86-94. PubMed ID: 10474063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frontal and thalamic changes of GABA concentration indicate dysfunction of thalamofrontal networks in juvenile myoclonic epilepsy.
    Hattingen E; Lückerath C; Pellikan S; Vronski D; Roth C; Knake S; Kieslich M; Pilatus U
    Epilepsia; 2014 Jul; 55(7):1030-7. PubMed ID: 24902613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gamma-aminobutyric-acid deficiency in brain of schizophrenic patients.
    Perry TL; Kish SJ; Buchanan J; Hansen S
    Lancet; 1979 Feb; 1(8110):237-9. PubMed ID: 84898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A two-process theory of schizophrenia: evidence from studies in post-mortem brain.
    Deakin JF; Simpson MD
    J Psychiatr Res; 1997; 31(2):277-95. PubMed ID: 9278190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Automatic relevance determination for identifying thalamic regions implicated in schizophrenia.
    Browne A; Jakary A; Vinogradov S; Fu Y; Deicken RF
    IEEE Trans Neural Netw; 2008 Jun; 19(6):1101-7. PubMed ID: 18541507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.
    Buchsbaum MS; Christian BT; Lehrer DS; Narayanan TK; Shi B; Mantil J; Kemether E; Oakes TR; Mukherjee J
    Schizophr Res; 2006 Jul; 85(1-3):232-44. PubMed ID: 16713185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.